Investors
Don't miss any news, subscribe to our press releases.
Annual General Meeting 2022
The shareholders of Sprint Bioscience AB (publ), reg. no. 556789-7557, are hereby invited to the Annual General Meeting on 11 May 2022.
(The full text of the invitation can be found in Press releases and as a PDF on this page)
Sprint Bioscience invites all shareholders to exercise their voting rights at the Annual General Meeting by advance voting in the order described below. Information on the resolutions passed at the AGM will be published on 11 May as soon as the outcome of the voting is finalised.
Shareholders may request in the advance voting form that resolutions on one or more of the matters on the proposed agenda below be postponed to a so-called continued general meeting, which may not be a pure advance voting meeting. Such continued meeting shall take place if the annual general meeting so decides or if shareholders holding at least one tenth of all shares in the company so request.
Right to participate
Those who are registered as shareholders in the share register maintained by Euroclear Sweden AB on 3 May 2022 and who have notified their participation by casting their advance vote to the company no later than 10 May 2022 have the right to participate in the Annual General Meeting by advance voting. See more information below on advance voting.
Nominee-registered shares
Shareholders whose shares are registered in the name of a nominee, i.e. held in a custody account by a bank or securities institution, must register the shares in their own name in order to be included as a shareholder in the production of the share register. Such registration, which may be temporary, must be completed by 5 May 2022, which means that the shareholder must instruct the nominee well in advance of this date.
Advance voting
The shareholders may exercise their voting rights at the meeting only by voting in advance, so-called postal voting, in accordance with section 22 of the Act (2022:121) on temporary exceptions to facilitate the execution of general meetings in companies and other associations.
A special form must be used for advance voting. The form is available at www.sprintbioscience.com. The advance voting form is valid as registration for the meeting.
The completed form must be received by the company no later than 10 May 2022 and sent to Sprint Bioscience c/o Fredersen Advokatbyrå, Lästmakargatan 18, 111 44 Stockholm or by e-mail to sprintbioscience@fredersen.se. If the shareholder votes in advance by proxy, a power of attorney must be attached to the form. If the shareholder is a legal entity, a copy of the registration certificate or other authorisation document must be enclosed with the form. The shareholder may not provide the advance vote with special instructions or conditions. If this happens, the vote (i.e. the advance vote in its entirety) is invalid. Further instructions and conditions are set out in the advance voting form.